Mara Dominis

Mara Dominis

Auto-generated profile, based on publicly available information

Mara Dominis

Department of Pathology and Cytology, Merkur University Hospital, Zajceva 19, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2014
Verified
Book Chapter
Closed access
MDMara Dominis
Mara Dominis
SDSonja Džebro
Sonja Džebro
SGSlavko Gašparov
Slavko Gašparov
APAnita Pešut
Anita Pešut
RKRajko Kusec
Rajko Kusec
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma, with an annual US incidence of >25,000 cases. Patients with DLBCL have highly variable course, response to treatment, and prognosis, which depend on many clinical, morphological, phenotypic, and genetic parameters. Nodal and extranodal DLBCLs differ in clinical presentation, behavior, and prognosis. DLBCL is composed of sheets of intermediate to large cells displaying centroblastic or immunoblastic cytomorphology. DLBCL with immunoblastic morphology is characterized by large nuclei with a fine chromatin and a single, centrally located prominent macronucleolus with variable amounts of eosinophilic to amphophilic cytoplasm. DLBCL with anaplastic features shows marked pleomorphism of tumor cells that may resemble Reed–Sternberg cells or carcinoma cells. Occasional cases of DLBCL form cohesive sheets of large cells with an amorphous myxoid background resembling metastatic carcinoma. The biological consequences of BCL6 expression in DLBCL might vary according to the presence or absence and the nature of the underlying alteration of the BCL6 gene.

1 September 2002
Verified
Journal Article
Closed access
MDMara Dominis
Mara Dominis
SDSonja Dzebro
Sonja Dzebro
SGSlavko Gasparov
Slavko Gasparov
MBMladen Buljevac
Mladen Buljevac
VCVesna Colić-Cvrlje
Vesna Colić-Cvrlje
MKMiroslava Katicić
Miroslava Katicić

1 September 2002
Verified
Journal Article
Closed access
MTMirjana Tićak
Mirjana Tićak
MPMarija Prskalo
Marija Prskalo
BSBranka Sabarić
Branka Sabarić
MDMara Dominis
Mara Dominis
BSBruno Skurla
Bruno Skurla
MKMiroslava Katicić
Miroslava Katicić

1 September 2002
Verified
Journal Article
Closed access
MPMarija Prskalo
Marija Prskalo
BSBranka Sabarić
Branka Sabarić
MTMirjana Tićak
Mirjana Tićak
BSBruno Skurla
Bruno Skurla
MDMara Dominis
Mara Dominis
MKMiroslava Katicić
Miroslava Katicić

1 January 1998 in Hematology
Verified
Journal Article
Closed access
MDMara Dominis
Mara Dominis
DIDavor Ivanković
Davor Ivanković
VKVesna Kuŝec
Vesna Kuŝec
RKRajko Kusec
Rajko Kusec
SDSonja Dẑebro
Sonja Dẑebro
In a group of 102 patients with myelodysplastic syndrome an evaluation of bone marrow biopsy was performed in order to assess prognostic impact on survival. The following characteristics were included in the analysis: cellularity, erythropoiesis, granulopoiesis, thrombopoiesis, lymphatic nodules, mastocytes, dyserythropoiesis, dysgranulopoiesis, dysthrombopoiesis, blasts, atypical localisation of immature precursor cells, fibrosis, osteoblasts and osteoclasts on bone surfaces. Data were statistically analysed by stepwise Cox proportional hazards regression. Survival was compared between FAB sub-classes, with better prognosis for RA and RARS patients and poor for CMML patients. Better survival was found in patients without dysgranulopoiesis and in those with osteoblasts on bone surfaces. Agreement with established prognostic factors indicates a representative sample. Relationship of osteoblasts to better survival shows involvement of bone tissue in MDS, suggesting it might be useful to include assessment of bone tissue features in histopathologic evaluation.